Gilead Sciences Inc. said its high blood pressure treatment candidate, darusentan, failed to meet the main goal of a late-stage clinical trial when compared to a placebo.
A company spokesman said the company...
Arkray’s blood glucose monitoring system receives government approval
Nov 05, 2009
Arkray Inc. announced that its Glucogard blood glucose monitoring system has received marketing approval from the Food and Drug Administration. The auto-coded product requires only 0.5 microliters of blood...
Hospice-home health merger to affect long-term care
By
Liza Berger
Jun 03, 2010
Developments in the hospice and home care markets may not generally catch the eyes of folks in the long-term care sphere. But that could change as a result of a recent transaction.
Venture fund invests in Diagnotes
By
Elizabeth Newman
Jan 09, 2019
The Indiana University Philanthropic Venture Fund has announced a $500,000 investment in Indianapolis-based Diagnotes Inc.
Diabetes patient support solution partners with Humana
Apr 26, 2017
Fit4D, which offers technology-enabled support for those with diabetes, announced a partnership with Humana Inc. on Tuesday.
Winnen moves to Noble
Dec 17, 2013
Stephan Winnen is the new managing director, Europe, at Noble Biomaterials Inc., the manufacturer of X-STATIC®.
A wound care assist
Mar 20, 2018
Massachusetts-based Organogenesis Inc. has announced the availability of PuraPly Antimicrobial in a new smaller 1.6 cm disc size.
CA community sells for $6M
By
Sep 05, 2016
CareTrust REIT Inc. has acquired a California skilled nursing facility for $6.9 million, the company announced in early August.
PDI names Cempellin as EVP and COO
Jul 11, 2014
Professional Disposables International, Inc., (PDI) has named Peter Cempellin as executive vice president and chief operating officer.
West Virginia may stall Manor Care purchase
By
Haymarket Media
Dec 03, 2007
The Manor Care Inc. acquisition is still in doubt after one state’s regulators agreed to reconsider an earlier approval of the deal.